Seoulin Bioscience Co.,Ltd. (KOSDAQ:038070)
South Korea flag South Korea · Delayed Price · Currency is KRW
6,590.00
-140.00 (-2.08%)
Last updated: Mar 24, 2025

Seoulin Bioscience Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Operating Revenue
75,41089,569104,70880,53965,085
Upgrade
Other Revenue
-0----
Upgrade
Revenue
75,41089,569104,70880,53965,085
Upgrade
Revenue Growth (YoY)
-15.81%-14.46%30.01%23.74%19.62%
Upgrade
Cost of Revenue
56,45069,69980,41759,46948,569
Upgrade
Gross Profit
18,96119,87124,29221,07016,516
Upgrade
Selling, General & Admin
14,69715,01612,47511,1449,626
Upgrade
Research & Development
1,214785.23870.46786.82998.37
Upgrade
Other Operating Expenses
483.24441.22396.47382.27335.09
Upgrade
Operating Expenses
18,00817,37615,09413,61912,046
Upgrade
Operating Income
952.672,4959,1987,4514,471
Upgrade
Interest Expense
-329.7-2,482-2,287-224.55-18.66
Upgrade
Interest & Investment Income
996.222,0511,637303.78253.7
Upgrade
Earnings From Equity Investments
88.5385.1121.01114.589.12
Upgrade
Currency Exchange Gain (Loss)
10.01-308.95-63.7-178.86144.62
Upgrade
Other Non Operating Income (Expenses)
666.373,4413,808-397.15724.33
Upgrade
EBT Excluding Unusual Items
2,3845,28012,4137,0695,664
Upgrade
Gain (Loss) on Sale of Investments
1,986-4,9662,011160.11118.2
Upgrade
Gain (Loss) on Sale of Assets
-13.69-31.42-1.0614,1530.27
Upgrade
Asset Writedown
-152.6--393.03-1,044-
Upgrade
Other Unusual Items
-648.11-2,211---
Upgrade
Pretax Income
3,556-1,92914,02920,3385,782
Upgrade
Income Tax Expense
415.34394.293,4644,459981.4
Upgrade
Earnings From Continuing Operations
3,140-2,32310,56515,8794,801
Upgrade
Earnings From Discontinued Operations
--29.47-111.04-
Upgrade
Net Income to Company
3,140-2,32310,59515,7684,801
Upgrade
Minority Interest in Earnings
-226.342,206-435.72-178.8891.64
Upgrade
Net Income
2,914-117.5510,15915,5894,893
Upgrade
Net Income to Common
2,914-117.5510,15915,5894,893
Upgrade
Net Income Growth
---34.84%218.64%-44.93%
Upgrade
Shares Outstanding (Basic)
99999
Upgrade
Shares Outstanding (Diluted)
991199
Upgrade
Shares Change (YoY)
-0.50%-19.46%23.72%-0.07%-1.26%
Upgrade
EPS (Basic)
334.30-13.421158.091773.24556.14
Upgrade
EPS (Diluted)
334.08-13.68798.151773.07555.99
Upgrade
EPS Growth
---54.98%218.90%-44.22%
Upgrade
Free Cash Flow
-4,660-14.95-4,8177,9843,283
Upgrade
Free Cash Flow Per Share
-534.60-1.71-442.90908.19373.19
Upgrade
Gross Margin
25.14%22.18%23.20%26.16%25.38%
Upgrade
Operating Margin
1.26%2.79%8.78%9.25%6.87%
Upgrade
Profit Margin
3.86%-0.13%9.70%19.36%7.52%
Upgrade
Free Cash Flow Margin
-6.18%-0.02%-4.60%9.91%5.04%
Upgrade
EBITDA
2,3183,78110,2159,3816,455
Upgrade
EBITDA Margin
3.07%4.22%9.75%11.65%9.92%
Upgrade
D&A For EBITDA
1,3651,2871,0171,9301,984
Upgrade
EBIT
952.672,4959,1987,4514,471
Upgrade
EBIT Margin
1.26%2.79%8.78%9.25%6.87%
Upgrade
Effective Tax Rate
11.68%-24.69%21.92%16.97%
Upgrade
Advertising Expenses
357.36227.45119.05141.61183.42
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.